Trademark: 79097290
Status Date
Sunday, February 14, 2021
Registration Number
4103838
Registration Date
Tuesday, February 28, 2012
Filing Date
Monday, February 14, 2011
Published for Opposition
Tuesday, December 13, 2011
Cancellation Date
Sunday, February 14, 2021
5 Pharmaceutical preparations, namely, anti-bacterial, anti-diabetic, anti-viral, anti-sickness, anti-infective and cardiovascular treatment pharmaceuticals, anti-allergic pharmaceutical preparations, pharmaceutical preparations for the treatment of infectious diseases and disorders of the central nervous system, pharmaceutical preparations for hormonal deficiencies, erectile dysfunction and reproductive dysfunction, pharmaceutical preparations for use in oncology; veterinary preparations, namely, therapeutic anti-infective, anti-bacterial, anti-sickness and anti-allergic pharmaceuticals and therapeutic veterinary preparations, namely, pharmaceuticals for the treatment of infectious diseases, hormonal deficiencies and for use in oncology, all for livestock and domestic animals; sanitary preparations for medical purposes; dietetic foods adapted for medical use; material for stopping teeth; vaccines
10 Surgical, medical, veterinary and dental devices, apparatus and instruments, namely, drug delivery systems, knives for surgical use, lasers for surgical and medical use, catheters for surgical use, and surgical and medical apparatus and instruments for use in general surgery; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials
35 Marketing services, namely, promoting or advertising the goods and services of others; marketing support services, namely, advertising and marketing of pharmaceutical and diagnostic preparations, therapeutics, medical apparatus, instruments and devices of third parties to enable them to be accepted and sold for worldwide distribution; creation of marketing partnerships between companies, namely, cooperative advertising and marketing of pharmaceutical companies as partners and their intellectual property licenses for the regulatory acceptance and sale of pharmaceuticals, medical apparatus, instruments and devices for worldwide distribution; advertising agencies; business development; consultation in the field of sales promotion services for business purposes; sourcing in the nature of procurement, namely, purchasing for others pharmaceutical products and medical apparatus, instruments and devices from third parties for worldwide distribution; import and export agencies; business auditing and preparation of business reports in the field of pharmaceutical products, and medical apparatus, instruments and device, for the purpose of regulatory guidance; executive recruiting services of management staff and personnel for pharmaceuticals and life sciences companies; business advisory and management services relating to company acquisitions and identifying and negotiating company acquisitions for third parties; business management and advisory services relating to obtaining marketing authorisations from relevant governing authorities in respect of pharmaceutical products, medical apparatus, instruments and devices; computerised database management; compilation and systemization of information into computer databases; commercial information agencies featuring a computer database; all of the aforesaid also provided online via the Internet or other interactive electronic platforms; information, advisory and consultancy services relating to all of the aforesaid
39 Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceutical products and medical apparatus, instruments and devices; information, advisory and consultancy services relating to the aforesaid
45 Licensing of pharmaceutical products; licensing of intellectual property for research and development purposes; licensing of intellectual property relating to pharmaceutical products, medical apparatus, instruments and devices; providing regulatory compliance information in the field of pharmaceuticals, medical devices, apparatus and instruments; information, advisory and consultancy services relating to all of the aforesaid
Nov 11, 2021
Withdrawal Of Attorney Granted
Nov 11, 2021
Teas Withdrawal Of Attorney Received
Nov 2, 2021
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Nov 2, 2021
Death Of International Registration
Nov 30, 2019
Total Invalidation Processed By The Ib
Jun 28, 2019
Total Invalidation Of Reg Ext Protection Sent To Ib
Jun 28, 2019
Invalidation Processed
Jun 5, 2019
Total Invalidation Of Reg Ext Protection Created
Oct 5, 2018
Cancelled Section 71
Feb 28, 2017
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Oct 20, 2016
New Representative At Ib Received
Feb 26, 2015
New Representative At Ib Received
Nov 14, 2014
New Representative At Ib Received
Dec 13, 2013
New Representative At Ib Received
Nov 15, 2012
Final Decision Transaction Processed By Ib
Oct 19, 2012
Final Disposition Notice Sent To Ib
Oct 19, 2012
Final Disposition Processed
Jul 1, 2012
Notification Processed By Ib
May 28, 2012
Final Disposition Notice Created, To Be Sent To Ib
Feb 28, 2012
Registered-Principal Register
Dec 13, 2011
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2011
Published For Opposition
Nov 23, 2011
Notification Of Possible Opposition Sent To Ib
Nov 23, 2011
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 23, 2011
Notification Of Notice Of Publication E-Mailed
Nov 4, 2011
Law Office Publication Review Completed
Nov 4, 2011
Assigned To Lie
Oct 9, 2011
Approved For Pub - Principal Register
Sep 14, 2011
Examiner's Amendment Entered
Sep 14, 2011
Notification Of Examiners Amendment E-Mailed
Sep 14, 2011
Examiners Amendment E-Mailed
Sep 14, 2011
Examiners Amendment -Written
Aug 20, 2011
Teas/Email Correspondence Entered
Aug 19, 2011
Correspondence Received In Law Office
Aug 19, 2011
Teas Response To Office Action Received
Jul 4, 2011
Refusal Processed By Ib
Jun 14, 2011
Application Filing Receipt Mailed
Jun 13, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Jun 13, 2011
Refusal Processed By Mpu
Jun 12, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Jun 11, 2011
Non-Final Action Written
Jun 10, 2011
Assigned To Examiner
Jun 10, 2011
New Application Office Supplied Data Entered In Tram
Jun 9, 2011
Limitation From Original Application Entered
Jun 9, 2011
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
